74 related articles for article (PubMed ID: 2965337)
1. Modulation of T3 antigen in systemic lupus erythematosus (SLE).
Surányi P; Czirják L; Szegedi G; Damjanovich S
Acta Med Hung; 1987; 44(4):311-9. PubMed ID: 2965337
[TBL] [Abstract][Full Text] [Related]
2. Modulation of IgM anti-lymphocyte antibody-reactive T cell surface antigens in systemic lupus erythematosus.
Winfield JB; Shaw M; Minota S
J Immunol; 1986 May; 136(9):3246-53. PubMed ID: 3007614
[TBL] [Abstract][Full Text] [Related]
3. Effect of T3 modulation on pokeweed mitogen-induced T cell activation: evidence for an alternative pathway of T cell activation.
Ceuppens JL; Meurs L; Baroja ML; Van Wauwe JP
J Immunol; 1986 May; 136(9):3346-50. PubMed ID: 3007616
[TBL] [Abstract][Full Text] [Related]
4. Low responsiveness to the anti Leu 4 antibody by T cells from patients with active systemic lupus erythematosus.
Kaneoka H; Morito F; Yamaguchi M
J Clin Lab Immunol; 1989 Jan; 28(1):15-26. PubMed ID: 2470907
[TBL] [Abstract][Full Text] [Related]
5. Impaired immunoregulation in systemic lupus erythematosus: defective adenosine-induced suppressor T lymphocyte generation.
Kammer GM; Birch RE; Polmar SH
J Immunol; 1983 Apr; 130(4):1706-12. PubMed ID: 6220065
[TBL] [Abstract][Full Text] [Related]
6. The circulating lymphocyte profiles in patients with discoid lupus erythematosus and systemic lupus erythematosus suggest a pathogenetic relationship.
Wouters CH; Diegenant C; Ceuppens JL; Degreef H; Stevens EA
Br J Dermatol; 2004 Apr; 150(4):693-700. PubMed ID: 15099365
[TBL] [Abstract][Full Text] [Related]
7. IgG anti-lymphocyte antibodies in systemic lupus erythematosus react with surface molecules shared by peripheral T cells and a primitive T cell line.
Minota S; Winfield JB
J Immunol; 1987 Mar; 138(6):1750-6. PubMed ID: 3102598
[TBL] [Abstract][Full Text] [Related]
8. Systemic lupus erythematosus sera antilymphocyte reactivity: detection of antibodies to Tac-antigen positive T cell lines.
Sano H; Kumagai S; Namiuchi S; Uchiyama T; Yodoi J; Maeda M; Takatsuki K; Suginoshita T; Imura H
Clin Exp Immunol; 1986 Jan; 63(1):8-16. PubMed ID: 3006953
[TBL] [Abstract][Full Text] [Related]
9. Expression and function of inducible costimulator on peripheral blood T cells in patients with systemic lupus erythematosus.
Yang JH; Zhang J; Cai Q; Zhao DB; Wang J; Guo PE; Liu L; Han XH; Shen Q
Rheumatology (Oxford); 2005 Oct; 44(10):1245-54. PubMed ID: 15987711
[TBL] [Abstract][Full Text] [Related]
10. Characterization of T lymphocyte subpopulations responsible for deficient interleukin 2 activity in patients with systemic lupus erythematosus.
Murakawa Y; Takada S; Ueda Y; Suzuki N; Hoshino T; Sakane T
J Immunol; 1985 Jan; 134(1):187-95. PubMed ID: 3917275
[TBL] [Abstract][Full Text] [Related]
11. Characterization of warm-reactive IgG anti-lymphocyte antibodies in systemic lupus erythematosus. Relative specificity for mitogen-activated T cells and their soluble products.
Litvin DA; Cohen PL; Winfield JB
J Immunol; 1983 Jan; 130(1):181-6. PubMed ID: 6600174
[TBL] [Abstract][Full Text] [Related]
12. Responsiveness of systemic lupus erythematosus T cells to signals provided through LCA T200 (CD45) and T1 (CD5) antigens.
Martorell J; Font J; Rojo I; Vilella R; Ingelmo M; Vives J
Clin Exp Immunol; 1989 Nov; 78(2):172-6. PubMed ID: 12412744
[TBL] [Abstract][Full Text] [Related]
13. Alterations of dendritic cells in systemic lupus erythematosus: phenotypic and functional deficiencies.
Scheinecker C; Zwölfer B; Köller M; Männer G; Smolen JS
Arthritis Rheum; 2001 Apr; 44(4):856-65. PubMed ID: 11315925
[TBL] [Abstract][Full Text] [Related]
14. Expression of B-cell activating factor of the tumour necrosis factor family (BAFF) in T cells in active systemic lupus erythematosus: the role of BAFF in T cell-dependent B cell pathogenic autoantibody production.
Morimoto S; Nakano S; Watanabe T; Tamayama Y; Mitsuo A; Nakiri Y; Suzuki J; Nozawa K; Amano H; Tokano Y; Kobata T; Takasaki Y
Rheumatology (Oxford); 2007 Jul; 46(7):1083-6. PubMed ID: 17500077
[TBL] [Abstract][Full Text] [Related]
15. Anti-lymphocyte antibodies in systemic lupus erythematosus.
Winfield JB
Clin Rheum Dis; 1985 Dec; 11(3):523-49. PubMed ID: 3907954
[TBL] [Abstract][Full Text] [Related]
16. [Interferon therapy effects on activation of T-lymphocytes in patients with systemic lupus erythematosus].
Stanislav ML; Balabanova RM; Nikonova MF; Litvina MM; Iarilin AA
Ter Arkh; 2000; 72(5):44-9. PubMed ID: 11109620
[TBL] [Abstract][Full Text] [Related]
17. Rapid T cell receptor modulation accompanies lack of in vitro mitogenic responsiveness of double negative T cells to anti-CD3 monoclonal antibody in MRL/Mp-lpr mice.
Davignon JL; Cohen PL; Eisenberg RA
J Immunol; 1988 Sep; 141(6):1848-54. PubMed ID: 3262641
[TBL] [Abstract][Full Text] [Related]
18. Antibody to activated lymphocytes in patients with systemic lupus erythematosus.
Kagami M; Koike T; Takabayashi K; Tomioka H; Yoshida S
J Rheumatol; 1987 Oct; 14(5):907-12. PubMed ID: 3123675
[TBL] [Abstract][Full Text] [Related]
19. Requirements for T cell activation by OKT3 monoclonal antibody: role of modulation of T3 molecules and interleukin 1.
Schwab R; Crow MK; Russo C; Weksler ME
J Immunol; 1985 Sep; 135(3):1714-8. PubMed ID: 3926880
[TBL] [Abstract][Full Text] [Related]
20. Induction of costimulation of human CD4 T cells by tumor necrosis factor-related apoptosis-inducing ligand: possible role in T cell activation in systemic lupus erythematosus.
Tsai HF; Lai JJ; Chou AH; Wang TF; Wu CS; Hsu PN
Arthritis Rheum; 2004 Feb; 50(2):629-39. PubMed ID: 14872508
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
